CONFERENCE BROCHURE
A limtied number of pitching companies have released their non-confidential slide decks, published on this site.
Event timezone:
My timezone:
NEXT YEAR'S CONFERENCE WILL BE ON 23 APRIL, 2026
WHY ATTEND?
On 3 April, 2025, over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, got together in London for the 21st Annual Anglonordic Life Science Conference.
The Reception, our must-attend networking event, took place the evening before at the London Institute for Healthcare Engineering.
The Conference was attended by 86 high quality investor firms, and featured on-point panel discussions around European investment and technologies, and 36 funding pitches presented by cutting-edge biomedical and healthcare startups. 1:1 partnering took place throughout the day, with every meeting slot filled.
With the support of M Ventures as lead and founding sponsor, and the generosity of the London Institute for Healthcare Engineering in providing their venue for The Reception for the second time, this edition of Anglonordic was one of the top networking and partnering events in the life sciences calendar, and the unique R&D-to-investor conference in the UK.
Keynote Speaker
Göran Ando MD, Chairman, Nouscom AG
ProgrammeThe Reception
Kindly hosted by:
Charity of the Year
400+ Attendees
Exclusively selected attendees represent the following key drivers of the European life sciences growth sector:
- CEOs, CSOs and Heads of Business Development from Emerging Life Science Companies in the Anglo-Nordic sphere and Continental Europe
- Decision-makers from Europe's key Investor firms and Pharma companies
- Key Supporters of the Life Science Ecosystem in Europe
- Country delegations: hand-picked growth companies from global life science clusters
80+ Investor Firms
Anglonordic celebrates a 21-year tradition of attracting leading lifescience investment firms with funds.
We are expecting over 80 investment firms to attend. Based across Europe, these funders have interests in a wide variety of technologies from small molecule discovery through protein technologies to AI applications and healthcare devices.
View the list of investors who have already committed to attend.
36 Startup Pitches
High quality, investor-selected growth companies
- Company pitches are selected by our investor panel from a broad set of applicants
- We encourage biotech, medtech and technology startups to apply
- Developing ground-breaking technologies, these companies will be seeking funding and/or collaborations
300+ Partnering Meetings
Networking and 1:1 meetings
Networking is high on the priority list for Anglonordic delegates. Business discussions start well ahead of the conference, via our networking and 1:1 meeting scheduling platform. The platform features rich company/investor profiling plus instant messaging. Over 1,000 meeting requests and 5,000 messages were sent last year.
FOUNDING SPONSOR
SILVER SPONSOR
RECEPTION SPONSOR
AFTERNOON DRINKS SPONSOR
SUPPORTING SPONSORS
MEDIA PARTNERS
